PHARMACYTE BIOTECH, INC. Equity Method Investments
PHARMACYTE BIOTECH, INC. (PMCB) had Equity Method Investments of $0 as of 2024-04-30, per its 10-K filed 2024-08-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:EquityMethodInvestments · last filed 2024-08-13
- 2024-04-30: Equity Method Investments $0.00.
- 2024-01-31: Equity Method Investments $1.57M.
- 2023-10-31: Equity Method Investments $1.57M.
- 2023-07-31: Equity Method Investments $1.57M.
| Period end | Equity Method Investments |
|---|---|
| 2024-04-30 | $0.00 10-K · filed 2024-08-13 |
| 2024-01-31 | $1.57M 10-Q · filed 2024-03-18 |
| 2023-10-31 | $1.57M 10-Q · filed 2023-12-15 |
| 2023-07-31 | $1.57M 10-Q · filed 2023-09-18 |
| 2023-04-30 | $1.57M 10-K · filed 2024-08-13 |
| 2023-01-31 | $1.57M 10-Q · filed 2023-03-16 |
| 2022-10-31 | $1.57M 10-Q · filed 2022-12-14 |
| 2022-07-31 | $1.57M 10-Q · filed 2022-09-14 |
| 2022-04-30 | $1.57M 10-K · filed 2023-07-31 |
| 2022-01-31 | $1.57M 10-Q · filed 2022-03-15 |
| 2021-10-31 | $1.57M 10-Q · filed 2021-12-14 |
| 2021-07-31 | $1.57M 10-Q · filed 2021-09-14 |
| 2021-04-30 | $1.57M 10-K · filed 2022-07-28 |
| 2021-01-31 | $1.57M 10-Q · filed 2021-03-12 |
| 2020-10-31 | $1.57M 10-Q · filed 2020-12-11 |
| 2020-07-31 | $1.57M 10-Q · filed 2020-09-11 |
| 2020-04-30 | $1.57M 10-K · filed 2021-08-10 |
| 2020-01-31 | $1.57M 10-Q · filed 2020-03-13 |
| 2019-10-31 | $1.57M 10-Q · filed 2019-12-23 |
| 2019-07-31 | $1.57M 10-Q · filed 2019-09-13 |
| 2019-04-30 | $1.57M 10-K · filed 2020-08-13 |
| 2019-01-31 | $1.57M 10-Q · filed 2019-03-14 |
| 2018-10-31 | $1.57M 10-Q · filed 2018-12-14 |
| 2018-07-31 | $1.57M 10-Q · filed 2018-09-12 |
| 2018-04-30 | $1.57M 10-K · filed 2019-08-13 |
| 2018-01-31 | $1.57M 10-Q · filed 2018-03-19 |
| 2017-10-31 | $1.57M 10-Q · filed 2017-12-14 |
| 2017-07-31 | $1.57M 10-Q · filed 2017-09-13 |
| 2017-04-30 | $1.57M 10-K · filed 2018-07-20 |
| 2017-01-31 | $1.57M 10-Q · filed 2017-03-13 |
| 2016-10-31 | $1.57M 10-Q · filed 2016-12-02 |
| 2016-07-31 | $1.57M 10-Q · filed 2016-09-06 |
| 2016-04-30 | $1.57M 10-K · filed 2017-07-27 |
| 2016-01-31 | $1.57M 10-Q · filed 2016-03-08 |
| 2015-10-31 | $1.57M 10-Q/A · filed 2016-01-19 |
| 2015-07-31 | $1.57M 10-Q/A · filed 2016-01-19 |
| 2015-04-30 | $1.57M 10-K · filed 2016-07-29 |
| 2015-01-31 | $1.57M 10-Q · filed 2015-03-13 |
| 2014-10-31 | $1.57M 10-Q · filed 2014-12-15 |
| 2014-07-31 | $1.57M 10-Q · filed 2014-09-15 |
| 2014-04-30 | $1.57M 10-K/A · filed 2016-01-19 |
| 2014-01-31 | $1.57M 10-Q · filed 2014-03-17 |
| 2013-10-31 | $1.57M 10-Q · filed 2013-12-16 |
| 2013-04-30 | $0.00 10-K · filed 2014-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |